1 - 101 of about 101
English: Yoshida M, Gotoh M, Yokoyama O, Kakizaki H, Yamanishi T, Yamaguchi O., Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study. , World Journal of Urology , vol.40 (11) (p.2799 - 2805) , 2022
English: Wada N, Ishikawa M, Nagabuchi M, Makino S, Miyauchi K, Abe N, Kakizaki H., Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder. , Int J Urology Case Reports , vol.5 (p.384 - 388) , 2022
English: Wada N, Abe N, Miyauchi K, Ishikawa M, Makino S, Kakizaki H., Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis. , Int Urol Nephrol , vol.54 (6) (p.1193 - 1198) , 2022
English: Takeda T, Shonaka T, Tani C, Hayashi T, Kakizaki H, Sumi Y., Gracilis muscle flap combined with a laparoscopic transabdominal approach is effective in the treatment of post-prostatectomy rectourethral fistula: A case report. , Int J Surgery Case Reports , vol.92 , 2022
English: Wada N, Abe N, Miyauchi K, Ishikawa M, Kakizaki H., Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement. , Int Urol Nephrol , vol.54 (1) (p.3 - 36) , 2022
English: Wada N, Watanabe M, Ishikawa M, Takeuchi K, Miyauchi K, Abe N, Banjo H, Kita M, Kakizaki H., Uroflowmetry pattern in detrusor underactivity and bladder outlet obstruction in male patients with lower urinary tract symptoms. , Lower Urinary Tract Symptoms , 2021
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K., Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. , Neurourology and Urodynamics , vol.40 (6) (p.1651 - 1660) , 2021
English: Katoh T, Kakizaki H, Lee KS, et al, Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post-hoc analysis from the MATCH study. , Lower Urinary Tract Symptoms , vol.13 (1) (p.98 - 107) , 2021
English: Kakizaki H, Lee KS, Katou D, Yamamoto O, Sumarsono B, Uno S, Yamaguchi O., Mirabegron add-on therapy to tamsulosin in men with overactive bladder: Post hoc analyses of efficacy from the MATCH study. , Advances in Therapy , 2020
English: Fukudo M, Tamaki G, Azumi M, Kakizaki H, Tasaki Y., Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma. , Investigational New Drugs , 2020
English: Kakizaki H, Wada N, Watanabe M, Kita M, Hori J, Tamaki G., Managing sphincter deficiency stress urinary incontinence in the neurogenic patients: Diagnosis and management strategies. , Current Bladder Dusfunction Reports , 2020
English: Katoh T, Kakizaki H, Lee KS, Ishida K, Katou D, Yamamoto O, Jong JJ, Sumarsono B, Uno S, Yamaguchi O., Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactivebladder in men with lower urinary tract symptoms: A post-hoc analysis from the MATCH study. , Lower Urinary Tract Symptoms , 2020
English: Wada N, Yoshimura N, Kurobe M, Saito T, Tyagi P, Kakizaki H., The early, long-term inhibition of brain-derived neurotrophic factor improves voidings and storage dysfunctions in mice with spinal cord injury. , Neurourology and urodynamics , vol.39 (5) (p.1345 - 1354) , 2020
English: Wada N, Kikuchi D, Tateoka J, Abe N, Watanabe M, Tamaki G, Kita M, Kakizaki H., Persistence rate with tadalafil for treatment of male lower urinary tract symptoms. , Urol Int , vol.29 (4) (p.1 - 5) , 2020
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K., Efficacy of vibegron, a novel β3-adrenoceptor agonist, on severe urgency urinary incontinence related to overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. , British Journal of Urology International , 2020
English: Sekido N, Igawa Y, Kakizaki H, Kitta T, Sengoku A, Takahashi S, Takahashi R, Tanaka K, Namima T, Honda M, Mitsui T, Yamanishi T,Watanabe T., Clinical guidelines for the diagnosis and treatment of lower urinary tract dysfunction in patients with spinal cord injury , International Journal of Urology , 2020
English: Wada N, Kikuchi D, Tateoka J, Abe N, Banjo H, Tsuchida M, Hori J, Tamaki G, Kita M, Kakizaki H., Long-term symptomatic outcome after transurethral resection of the prostate: A urodynamic-based assessment. , International Journal of Urology , vol.26 (11) (p.1071 - 1075) , 2019
English: Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A and Kuroishi K., Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to miranegron monotherapy: A multicenter, randomozed study in Japan (MILAI II study) , International Journal of Urology , vol.26 (3) (p.342 - 352) , 2019
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K and Minemura K.:, Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. , International Journal of Urology , vol.26 (3) (p.369 - 375) , 2019
English: Rosier PFW, Kuo HC, De Gennaro M, Gammie A, Agro EF, Kakizaki H,Hashim H, Toozs-Hobson P., International Consultation on Incontinence 2016; Executive summary: Urodynamic testing. , Neurourology and urodynamics , vol.38 (2) (p.545 - 552) , 2019
English: Kakizaki H, Lee K-S, Yamamoto O, Jong JJ, Katou D, Sumarsono B, Uno S, Yamaguchi O.:, Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A randomized, placebo-controlled study (MATCH). , European Urology Focus , 2019
English: Wada N, Shimizu T, Shimizu N, Kurobe M, de Groat WC, Tyagi P, Kakizaki H, Yoshimura N., Therapeutic effects of inhibition of brain-derived neurotrophic factor on voiding dysfunction in mice with spinal cord injury. , Am. J. Physiol. Renal Physiol. , vol.317 (5) (p.F1305 - F1310) , 2019
English: Yoshida M, Kakizaki H, Takahashi S, Nagai S, Kurose T., Long-term safety and efficacy of the novel β3-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study. , International Journal of Urology , vol.25 (7) (p.668 - 675) , 2018
English: Wada N, Watanabe M, Banjo H, Tsuchida M, Hori G, Tamaki G, Azumi M, Kita M, Kakizaki H., A long-term persistence with mirabegron in a real world clinical setting. , International Journal of Urology , vol.25 (5) (p.501 - 506) , 2018
English: Hori J, Koga D, Kakizaki H, Watanabe T., Differential effects of depot formulations of GnRH agonist leuprorelin and antagonist degarelix on the seminiferous epithelium of the rat testis. , Biomedical Research , vol.39 (4) (p.197 - 214) , 2018
English: Wada N, Shimizu T, Shimizu N, de Groat WC, Kanai AJ, Tyagi P, Kakizaki H, Yoshimura N., The effect of neutralization of nerve growth factor (NGF) on bladder and urethral dysfunction in mice with spinal cord injury. , Neurourology and Urodynamics , 2018
English: Wada N, Kadekawa K, Majima T, Shimizu T, Tyagi P, Kakizaki H, Yoshimura N., Urodynamic effects of intravenous and intrathecal administration of E-series prostaglandin 1 receptor antagonist on detrusor overactivity in rats with spinal cord injury. , Neurourology and Urodynamics , vol.37 (1) (p.132 - 137) , 2018
English: Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A and Kuroishi K., Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI Ⅱ study) , International Journal of Urology , 2018
English: Rosier PFW, Kuo HC, De Gennaro M, Gammie A, Agro EF, Kakizaki H,Hashim H, Toozs-Hobson P., International Consultation on Incontinence 2016; Executive summary: Urodynamic testing. , Neurourology and Urodynamics , 2018
English: Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Hashimoto K and Minemura K., Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study. , International Journal of Urology , 2018
English: Hori J, Kobayashi S, Tamaki G, Azumi M, Kakizaki H., Diagnostic efficacy of percutaneous renal tumor biopsy –Concomitant use of frozen section to accurately diagnose renal tumor with necrosis. , Japanese Journal of Cancer Chemotherapy , vol.44 (9) (p.771 - 774) , 2017
English: Wada N, Shimizu T, Takai S, Shimizu N, Kanai AJ, Tyagi P, Kakizaki H, Yoshimura N., Post-injury management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury , Neurourology and Urodynamics , vol.36 (5) (p.1301 - 1305) , 2017
English: Wada N, Shimizu T, Takai S, Shimizu N, Tyagi P, Kakizaki H, Yoshimura N, Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinalcord injury , Neurourology and Urodynamics , vol.36 (4) (p.1039 - 1045) , 2017
English: Hori J, Wada N, Tamaki G, Azumi M, Kita M, Iwata T, Matsumoto S, Kakizaki H., Combination of GnRH antagonist degarelix and antiandrogen is effective in PSA reduction and bone management in patients with prostate cancer. , Japanese Journal of Cancer Chemotherapy , vol.43 (6) (p.727 - 731) , 2016
English: Wada N, Iuchi H, Kita M, et al, Urodynamic efficacy and safety of mirabegron add-on treatment with tamsulosin for Japanese male patients with overactive bladder , LUTS , 2016 , (IF:0.239)
English: Wada N, Hashizume K, Matsumoto S, Kakizaki H., Dutasteride improves bone mineral density in male patients with lower urinary tractsymptoms and prostatic enlargement: a preliminary study , Aging Male , 2016
English: Watanabe M, Suzuki Y, Uchida K, et al, Trpm7 contributes to intercellular junction formation in mouse urothelium , J Biol Chem , vol.290 (50) (p.29882 - 29892) , 2015
English: Wada N, Ameda K, Furuno T, Okada H, Date I, Kakizaki H, Evaluation of Prostaglandin E2 and E-series prostaglandin receptor in patients with intetstitial cystitis , The Journalof Urology , vol.193 (6) (p.1987 - 1993) , 2015 , (IF:3.746)
English: Naoki Wada, et al, Improvement of overactive bladder symptoms and bladder ischemia with dutasteride in patients with benign prostatic enlargement , LUTS , vol.7 (1) (p.37 - 41) , 2015
English: Seiji Matsumoto, et al, Association between chronic periodontal disease and lower urinary tract symptoms in both sexes , LUTS , vol.7 (1) (p.17 - 21) , 2015
English: Yamaguchi O, Kakizaki H, Homma Y, et al, Safety and efficacy of mirabegron as add-on therapy in patients with overactive bladder treated with solifenacin: a postmarketing, open-label study in Japan (MILAI study) , BJU Int , vol.116 (p.612 - 622) , 2015 , (IF:3.682)
English: Naoki Wada, et al, Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride , International Journal of Urology , vol.21 (12) (p.1258 - 1262) , 2014
English: Seiji Matsumoto, et al, Effects of chronic treatment with cilostazol, a phosphodiesterase 3 inhibitor, on female rat bladder in a partial bladder outlet obstruction model , Urology , vol.83 (3) (p.675.e7 - 675.e11) , 2014
English: Wada N, Numata A, Hou K, Watanabe M, Kita M, Matsumoto S, Osanai H, Fujisawa M, Kakizaki H, Nocturia and sleep quality after transurethral resection of the prostate , International Journal of Urology , vol.21 (1) (p.81 - 85) , 2014
English: Matsumoto S, Matsuda M, Takekawa M, Okada M, Hashizume K, Wada N, Hori J, Tamaki G, Kita M, Iwata T, Kakizaki H, Association of ED with chronic periodontal disease , International Journal of Impotence Research , vol.26 (p.13 - 15) , 2014
English: Tadasu Motoya, et al, The impact of abdominal aortic caicification and visceral fat obesity on lower urinary tract symptoms in patients with benign prostatic hyperplasia , International Urology and Nephrology , vol.46 (p.1877 - 1881) , 2014
English: Wada N, Kita M, Hashizume K, Matsumoto S, Kakizaki H, Urodymanic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: Prospective pressure-flow study , Neurourology and Urodynamics , vol.32 (8) (p.1123 - 1127) , 2013
English: Kawai Y, Oka M, Kyotani J, Oyama T, Matsumoto S, Kakizaki H , Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying , Neurourology ad Urodynamics , vol.32 (7) (p.1031 - 1037) , 2013
English: Ishizuka O, Matsuyama H, Sakai H, Matsubara A, Nagaoka A, Takahashi S, Takeda M, Ozono S, Shiroki R, Shuin T, Hara I, Kakizaki H, Tsukamoto T, Yamanishi T, Yokoyama O, Kakehi Y, Nishizawa O, and The KING Study Group, Nocturia potentially influences maintenance of sexual function in elderly men with benign prostatic hyperplasia. , LUTS , vol.5 (2) (p.75 - 81) , 2013
English: Yamaguchi S, Osanai H, Numata A, Watanabe M, Kakizaki H., Alpha 1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: Efficacy of dose increase therapy. , International Journal of Urology , vol.20 (5) (p.513 - 519) , 2013
English: Matsumoto S, Hashizume K, Watanabe M, Wada N, Hori J, Tamaki G, Kita M, Iwata T, Kakizaki H., Relationship between overactive bladder and irritable bowel syndrome: A large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria. , BJU International , vol.111 (p.647 - 652) , 2013
English: Matsumoto S, Ueda T, Kakizaki H.:, Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome. , Urology , vol.81 (226) (p.230 - 2013) , 2013
English: Wada N, Matsumoto S, Kita M, Watanabe M, Hashizume K, Kakizaki H., The effect of intrathecal administration of E-series prostaglandin (EP) 1 receptor antagonist in cyclophosphamide induced cystitis rats. , International Journal of Urology , vol.20 (2) (p.235 - 240) , 2013
English: Wada N, Watanabe M, Kita M, Matsumoto S, Osanai H, Yamaguchi S, Numata A, Fujisawa M, Saga Y, Hou K, Iuchi H, Niibori D, Kura T, Taniguchi A, Kunieda M, Nakata Y, Kakizaki H., Effect of imidafenacinon nocturia and sleep disorder in patients with overactive bladder. , Urologia Internationalis , vol.89 (p.215 - 221) , 2012
English: Wada N, Watanabe M, Kita M, Matsumoto S, Kakizaki H., Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction , Neurourology and Urodynamics , vol.31 (p.659 - 663) , 2012
English: Matsumoto S, Kakizaki H, Causative significance of bladder blood flow in lower urinary tract symptoms , International Journal of Urology , vol.19 (1) (p.20 - 25) , 2012 , (IF:1.747)
English: Wada et al, Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction , Neurourology and Urodynamics , vol.31 (p.659 - 663) , 2012 , (IF:2.958)
English: Hommma et al, Assessment of overactive bladder symptoms: Comparison of 3-day bladder diary and the overactivebladder symptoms score , Urology , vol.77 (p.60 - 64) , 2011 , (IF:2.428)
English: Wada et al, Efficacy and safety of propiverine and solifenacin for the treatment of female patients with overactive bladder: A crossover study , LUTS , vol.3 (p.36 - 42) , 2011 , (IF:0.239)
English: Yokoyama et al, Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: Impact on sleep evaluated by bladder diary. , Journal of Urology , vol.186 (p.170 - 174) , 2011 , (IF:3.746)
English: Yamaguchi et al, Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms , Urology , vol.78 (p.126 - 133) , 2011 , (IF:2.428)
English: Kakizaki H, Kita M, Wada N, Models for sensory neurons of dorsal root ganglia and stress urinary incontinence. , Neurourology and Urodynamics , vol.30 (p.653 - 657) , 2011 , (IF:2.958)
English: Sata et al, Genetic polymorphisms of 17β-hydroxysteroid dehydrogenase 3 and the risk of hypospadias. , Journal of Sexual Medicine , vol.7 (8) (p.2729 - 2738) , 2010 , (IF:3.552)
English: Azumi et al, Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer. , Journal of Urology , vol.183 (p.2036 - 2044) , 2010 , (IF:3.746)
English: Takeda et al, Predictive factors for the effect of the α1-D/A , BJU Int , vol.108 (p.100 - 107) , 2010 , (IF:2.844)
English: Kita et al, Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladder. , Am. J. Physiol. Regul. Integr. Com. Physiol. , vol.298 (p.R1310 - R1319) , 2010 , (IF:3.682)
English: Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, Obara K, Gotoh M, Igawa Y, Seki N, Yoshida M, Clinical guidelines for overactive bladder. , Int. J. Urol. , vol.16 (p.126 - 142) , 2009 , (IF:1.747)
English: Kakizaki H, Yoshiyama M, Role of central 5-hydroxytryptamine receptors in micturition control. , LUTS , vol.1 (p.S36 - S39) , 2009
English: Kakizaki H, Tanaka H, Mitsui T, Nonomura K, Clinical efficacy of a1- blocker Naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia. , LUTS , vol.1 (p.35 - 39) , 2009 , (IF:0.239)
English: Numata A., Iwata T., Iuchi H., Taniguchi N., Kita M., Wada N., Kato Y., Kakizaki H, Micturition-suppressing region in the periaqueductal gray of the mesencephalon of the cat. , Am. J. Physiol. Regul. Integr. Comp. Physiol. , vol.294 (p.R1996 - R2000) , 2008
English: Kato Y., Okuyama M., Kakizaki H, A slow delivery rate of shockwaves causes less pain in extracorporeal lithotripsy , Jpn. J. Endourol. ESWL , vol.21 (p.219 - 224) , 2008
English: Kato Y, Taniguchi N, Okuyama M, Kakizaki H, 【症例報告】Three cases of urolithiasis associated with sarcoidosis: A review of Japanese cases. , Int. J. Urol , vol.14 (p.954 - 956) , 2007
English: Azumi M., Hou K., Numata A., Taniguchi N., Saga Y., Hashimoto H., Kakizaki H, 【症例報告】 Case report of renal pelvic adenocarcinoma associated with a renal stone that produced carbohydrate antigen 125 and carbohydrate antigen 19-9. , Acta Urol. Jpn , vol.53 (p.631 - 634) , 2007
English: Kato Y., Wada N., Numata A., Kakizaki H, 【症例報告】Case of hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome associated with nephrocalcinosis and distal renal tubular acidosis , Int. J. Urol. , vol.14 (p.440 - 442) , 2007
English: Mitsui T., Tanaka H., Moriya K., Kakizaki H., Nonomura K, Clinical and urodynamic outcomes of pubovaginal sling procedure with autologous rectus fascia for stress urinary incontinence. , Int. J. Urol , vol.14 (p.1076 - 1079) , 2007 , (IF:0.691)
English: Kita M., Tamaki G., Okuyama M., Saga Y., Kakizaki H, Adrenalectomy for metastatic adrenal tumors. , Acta. Urol. Jpn , vol.53 (p.761 - 766) , 2007
English: Nonomura K., Kakizaki H., Tanaka H., Moriya K., Mitsui T., Ten-year consecutive experience with cystourethroscopic procedures in children: Hokkaido University experience. , Jpn. J. Endourol ESWL, , vol.20 (p.271 - 274) , 2007
English: Kitahara K., Sakai Y., Hosaka M., Hira Y., Kakizaki H., Watanabe T, Effects of a depot formulation of the GnRH agonist leuprorelin on the ultrastructure of male rat pituitary gonadotropes. , Arch. Histol. Cytol., , vol.70 (2) (p.79 - 93) , 2007 , (IF:1.392)
English: Yamaguchi O., Marui E., Kakizaki H., Itoh N., Yokota T., Okada H., Ishizuka O., Ozono S., Gotoh M., Sugiyama T., Seki N., Yoshida M, Randomized, double-blind, placebo- and propiverine-controlled trial of theonce-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. , BJU Int. , vol.100 (p.579 - 587) , 2007 , (IF:2.635)
English: Kitta T., Kakizaki H., Tanaka H., Sano H., Furuno T., Mitsui T., MoriyaK., Nonomura K, An α-amino-3-hydroxy-5-methy- 4-isoxazolepropio- nate glutamate-receptor antagonist can inhibit premicturition contractionsin rats with bladder outlet obstruction. , BJU Int. , vol.100 (p.181 - 186) , 2007 , (IF:2.635)
English: Kobayashi H., Nagato T., Sato K., Aoki N., Kimura S., Murakami M., Iizuka H., Azumi M., Kakizaki H., Tateno M., Celis E:, Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner. , Cancer Res , vol.67 (11) (p.5498 - 5504) , 2007 , (IF:7.656)
English: Kato Y., Numata A., Wada N., Iwata T., Saga Y., Hashimoto H., Kakizaki H, 【症例報告】A case of metastatic renal cell carcinoma to the ovary, , Acta Urol. Jpn , vol.52 (p.923 - 927) , 2006
English: Kitta T., Kakizaki H., Furuno T., Moriya K., Tanaka H., Shiga T., Tamaki N., Yabe I., Sasaki H., Nonomura K, Brain activation during detrusor overactivity in patients with Parkinson's disease：A positron emission tomography study, , J. Urol. , vol.175 (p.994 - 998) , 2006 , (IF:3.956)
English: Osawa T., Watarai Y., Morita K., Kakizaki H., Nonomura K, Surgery for giant high-flow renal arteriovenous fistula： experience in one institution , BJU Int. , vol.97 (p.794 - 798) , 2006 , (IF:2.635)
English: Homma Y., Yoshida M., Seki N., Yokoyama O., Kakizaki H., Gotoh M., Yamanishi T., Yamaguchi O., Takeda M., Nishizawa O.:, Symptom assessment tool for overactive bladder syndrome ? Overactive bladder symptom score, , Urology, , vol.68 (p.318 - 323) , 2006 , (IF:2.13)
English: Moriya K., Kakizaki H., Tanaka H., Furuno T., Higashiyama H., Sano H., Kitta T., Nonomura K, Long-term cosmetic and sexual outcome of hypospadias surgery： Norm related study in adolescence, , J. Urol., , vol.176 (p.1889 - 1893) , 2006 , (IF:3.956)
English: Homma Y., Yamaguchi O., Hayashi K., Kakizaki H., Gotoh M., Takeda M., Takei M., Nishizawa O., Yamanishi T., Yokoyama O, Epidemiologic survey of lower urinary tract symptoms in Japan , Urology , vol.68 (p.560 - 564) , 2006 , (IF:2.13)
English: Kato Y., Yamaguchi S., Hori J., Okuyama M., Kakizaki H, Improvement of stone comminution by slow delivery rate of shock waves in extracorporeal lithotripsy, , Int. J. Urol. , vol.13 (p.1461 - 1465) , 2006 , (IF:0.691)
English: Ameda K., Kakizaki H., Koyanagi T., Hirakawa K., Kusumi T., Hosokawa M, The long-term voiding function and sexual function after pelvic nerve-sparing radical surgery for rectal cancer, , Int. J. Urol , vol.12 (p.256 - 263) , 2005 , (IF:0.629)
English: Moriya K., Kakizaki H., Watanabe S., Sano H., Nonomura K, Mesenchymal cells infiltrating a bladder acellular matrix gradually lose smooth muscle characteristics in intraperitoneally regenerated urothelial lining tissue in rats, , BJU Int , vol.96 (p.152 - 157) , 2005 , (IF:2.247)
English: Homma Y., Yamaguchi O., Hayashi K., Kakizaki H., Gotoh M., Takeda M., Takei M., Nishizawa O., Yamanishi T., Yokoyama O, An epidemiological survey of overactive bladder symptoms in Japan , BJU Int , vol.96 (p.1314 - 1318) , 2005 , (IF:2.247)
English: Kurahashi N., Sata F., Kasai S., Shibata T., Moriya K., Yamada H., Kakizaki H., Minakami H., Nonomura K., Kishi R, Maternal genetic polymorphisms in CYP1A1, GSTM1 and GSTT1 and the risk of hypospadias, , Mol Hum Reprod. , vol.11 (p.93 - 98) , 2005 , (IF:3.191)
English: Kurahashi N., Kasai S., Shibata T., Kakizaki H., Nonomura K., Sata F., Kishi R, Parental neonatal risk factors for cryptorchidism, , Med Sci Monit , vol.11 (p.CR274 - CR283) , 2005
English: Kato Y., Yamaguchi S., Kakizaki H., Yachiku S, Influence of estrus status on urinary chemical parameters related to urolithiasis, , Urol Res , vol.33 (p.476 - 480) , 2005 , (IF:1.367)
English: Kitta T., Kakizaki H., Iwami D., Tanda K, 【症例報告】Successful bladder management for a pure urogenital sinus anomaly, , Int. J. Urol , vol.11 (p.340 - 342) , 2004
English: Yaguchi H., Soma H., Miyazaki Y., Tashiro J., Yabe I., Kikuchi S., Sasaki H., Kakizaki H., Morikawa F., Tashiro K, 【症例報告】A case of acute urinaryretention caused by periaqueductal grey lesion, , J. Neurol. Neurosurg. Psychiatr , vol.75 (p.1202 - 1203) , 2004
English: Shimada K., Kakizaki H., Kubota M., Taki M., Takeuchi H., Hiramatsu Y., Hosokawa S., Hosoda Y., Nakai H., Yamaguchi T, Standard method for diagnosing dilatation of the renal pelvis and ureter discovered in the fetus, neonate or infant, , Int. J. Urol , vol.11 (p.129 - 132) , 2004
English: Kurahashi N., Murakumo M., Kakizaki H., Nonomura K., Koyanagi T., Kasai S., Sata F., Kishi R, The estimated prevalence of hypospadias in Hokkaido, Japan , J. Epidemiol. , vol.14 (p.73 - 77) , 2004
Japanese: Treatment outcome of ureteral reconstruction surgery , vol.68 (7) (p.227 - 231) , 2022
Japanese: Clinical significance of preoperative image classification systems in robot-assisted laparoscopic partial nephrectomy , vol.68 (5) (p.133 - 138) , 2022
Japanese: Effects of imidafenacin on urine production rate, voided volume, and hours of undisturbed sleep in overactive bladder patients with nocturnal polyuria - a post hoc analysis of two clinical trials - , vol.31 (3) (p.305 - 311) , 2018
Page: [<<PREV] [1] [NEXT>>]
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.